These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9605581)

  • 1. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
    Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
    Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
    Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
    Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
    Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
    Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.
    Cronstein BN; Rosenstein ED; Kramer SB; Weissmann G; Hirschhorn R
    J Immunol; 1985 Aug; 135(2):1366-71. PubMed ID: 2989364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
    Cunha RA; Constantino MD; Ribeiro JA
    Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
    Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A
    Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.
    Varani K; Gessi S; Merighi S; Iannotta V; Cattabriga E; Spisani S; Cadossi R; Borea PA
    Br J Pharmacol; 2002 May; 136(1):57-66. PubMed ID: 11976268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    Merighi S; Varani K; Gessi S; Cattabriga E; Iannotta V; Ulouglu C; Leung E; Borea PA
    Br J Pharmacol; 2001 Nov; 134(6):1215-26. PubMed ID: 11704641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
    Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding.
    Varani K; Gessi S; Dalpiaz A; Borea PA
    Br J Pharmacol; 1996 Apr; 117(8):1693-701. PubMed ID: 8732278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.
    Diniz C; Fresco P; Leal S; Gonçalves J
    Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
    J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A; Fenu S; Morelli M
    Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.